Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    19223496 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Everolimus;   Drug: Placebo (for Everolimus)

Study has passed its completion date and status has not been verified in more than two years.